ZyVersa Therapeutics (ZVSA) Price-to-Earnings (P/E) Ratio
Price: $0.6751
Market Cap: $2.44M
Avg Volume: 2.32M
Market Cap: $2.44M
Avg Volume: 2.32M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
ZyVersa Therapeutics's P/E ratios across different time periods:
- TTM: 0.00
- Annual: 0.00
- Quarterly: -2.07
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 0.00
- Price-to-Sales (P/S) Ratio: 0.00
Annual Ratios
ZyVersa Therapeutics Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
0.00
P/B Ratio (Annual)
0.00
P/S Ratio (Annual)
0.00
ZyVersa Therapeutics Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | 0.00 | 0.00 | 0.00 |
| 2023 | -0.01 | 0.08 | 0.00 |
| 2022 | -0.02 | 0.14 | 0.00 |
| 2021 | -18.00 | -12.83 | 0.00 |
| 2020 | -12.15 | -18.73 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for ZVSA.